AAV for ovarian cancer gene therapy

Hee Chan Yoo, Sangkil Lee, Joong Yull Park, Eun-Ju Lee

Open source

DOI
10.1038/s41417-025-00926-4
Published
2025-06-20
Container
Cancer Gene Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41417-025-00926-4,
  title = {AAV for ovarian cancer gene therapy},
  author = {Hee Chan Yoo and Sangkil Lee and Joong Yull Park and Eun-Ju Lee},
  year = {2025},
  journal = {Cancer Gene Therapy},
  doi = {10.1038/s41417-025-00926-4},
  url = {https://doi.org/10.1038/s41417-025-00926-4}
}

RIS

TY  - JOUR
TI  - AAV for ovarian cancer gene therapy
AU  - Hee Chan Yoo
AU  - Sangkil Lee
AU  - Joong Yull Park
AU  - Eun-Ju Lee
PY  - 2025
JO  - Cancer Gene Therapy
DO  - 10.1038/s41417-025-00926-4
UR  - https://doi.org/10.1038/s41417-025-00926-4
ER  - 

APA

Yoo, H. C., Lee, S., Park, J. Y., & Lee, E. (2025). AAV for ovarian cancer gene therapy. Cancer Gene Therapy. https://doi.org/10.1038/s41417-025-00926-4

Source records